This week’s topics include the PROMISE trial, the efficacy of folic acid therapy in primary prevention of stroke among patients with hypertension in China, and more.
Manesh R. Patel discusses his research group’s retrospective analysis of data on digoxin use among patients with atrial fibrillation in the ROCKET AF trial.
AHA President Elliott Antman discusses the recent scientific statement from the AHA/ACC/ASH on the treatment of hypertension in patients with existing CAD.
Dr. Craig Cocchio discussing changes to the contraindications for acute ischemic stroke, about which the FDA has been curiously silent.
This week’s topics include two papers comparing everolimus-eluting stents and CABG and a study of short-term exposure to air pollution and stroke.
Jean-Pierre Usdin is frustrated with his “Tobacco-Free” hospital’s accommodations for smokers that encourage them to keep smoking instead of supporting them to quit.
The PROMISE trial, which was presented and discussed in a Journal Club forum at ACC.15, prompted some interesting discussion when CardioExchange covered it as a news story on March 14. Dr. Daniel B. Mark, one of the PROMISE investigators, now sheds further light on the trial in response to questions from CardioExchange news writer Larry…
This week’s topics include antiplatelet therapy duration following bare metal or drug-eluting coronary stents, thrombolysis in acute ischemic stroke, and more.
Saurav Chatterjee reports from the 2015 ACC conference with even more exciting opportunities for fellows in training and other health care professionals.
Saurav Chatterjee reports on exciting opportunities for fellows in training available at the 2015 ACC conference.